10-Q Filing

ACCELERATE DIAGNOSTICS, INC CIK: 727207 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001000096-13-000101`
Period End Date	20130630
Filing Date	20130809
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	axdx-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 60 Cash Flow Statement 46

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	45.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	25.33M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.17M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	38.85M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.78M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	25.33M	shares	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$763.90K	USD	Point-in-time
Trade accounts receivable	`ReceivablesNetCurrent`	$818.42K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	38.85M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$16.38K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$122.01K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.85M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$147.81K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$930.05K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$319.28K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$288.29K	USD	Point-in-time
Total Assets	`Assets`	$29.33M	USD	Point-in-time
Total Assets	`Assets`	$13.32M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$321.67K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$299.65K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$912.40K	USD	Point-in-time
Accrued compensation and other liabilities	`EmployeeRelatedLiabilitiesCurrent`	$870.38K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$573.15K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$78.03K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.81M	USD	Point-in-time
Long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	-	USD	Point-in-time
Long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$1.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.25M	USD	Point-in-time
Common stock, $0.001 par value; 45,000,000 shares authorized; 38,845,209 (2013) and 25,331,939 (2012) shares issued and outstanding	`CommonStockNoParValue`	$25.33K	USD	Point-in-time
Common stock, $0.001 par value; 45,000,000 shares authorized; 38,845,209 (2013) and 25,331,939 (2012) shares issued and outstanding	`CommonStockNoParValue`	$38.87K	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$53.01M	USD	Point-in-time
Contributed capital	`AdditionalPaidInCapitalCommonStock`	$31.24M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-25.53M	USD	Point-in-time
Accumulated deficit	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.20M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$12.07M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$27.52M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$29.33M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$13.32M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
OptiChem revenue	`LicensesRevenue`	$7.37K	USD	1 Quarter
OptiChem revenue	`LicensesRevenue`	$31.92K	USD	2 Qtrs
OptiChem revenue	`LicensesRevenue`	$23.05K	USD	2 Qtrs
OptiChem revenue	`LicensesRevenue`	$22.72K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$31.92K	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$22.72K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$7.37K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$23.05K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$104.57K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$202.75K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.34M	USD	2 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.16M	USD	2 Qtrs
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.23M	USD	1 Quarter
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$998.80K	USD	1 Quarter
Sales, general and administrative	`GeneralAndAdministrativeExpense`	$1.86M	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$128.76K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$64.50K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$19.43K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$38.48K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$106.95K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$1.03K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$70.57K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$515.00	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$6.35M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$1.17M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$1.49M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.46M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.33M	USD	2 Qtrs
Other expense	`OtherCostAndExpenseOperating`	-	USD	1 Quarter
Other expense	`OtherCostAndExpenseOperating`	$1.48K	USD	2 Qtrs
Other expense	`OtherCostAndExpenseOperating`	$1.12K	USD	1 Quarter
Other expense	`OtherCostAndExpenseOperating`	$1.78K	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$3.98K	USD	2 Qtrs
Interest and dividend income	`OtherNonoperatingIncome`	$4.06K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$2.16K	USD	1 Quarter
Interest and dividend income	`OtherNonoperatingIncome`	$7.89K	USD	2 Qtrs
Unrealized holding gain on investments	`UnrealizedGainLossOnInvestments`	$33.39K	USD	2 Qtrs
Unrealized holding gain on investments	`UnrealizedGainLossOnInvestments`	$17.77K	USD	1 Quarter
Unrealized holding gain on investments	`UnrealizedGainLossOnInvestments`	-	USD	2 Qtrs
Unrealized holding gain on investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.04K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$21.83K	USD	1 Quarter
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$39.49K	USD	2 Qtrs
Total other income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.50K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.42M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.78M	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.18	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	38.84M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.78M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	11.44M	shares	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	34.04M	shares	2 Qtrs

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-6.33M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.42M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.78M	USD	1 Quarter
Depreciation	`Depreciation`	$1.03K	USD	2 Qtrs
Depreciation	`Depreciation`	$106.95K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$128.76K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$64.50K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$19.43K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$38.48K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.60M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$75.08K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.10K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-54.52K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-105.63K	USD	2 Qtrs
Prepaid expense and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$4.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$22.02K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-20.87K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$6.58K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$42.01K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-11.82K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$495.12K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	$-37.50K	USD	2 Qtrs
Deferred compensation	`DeferredCompensationArrangementWithIndividualCompensationExpense`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.28M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.18M	USD	2 Qtrs
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$896.67K	USD	2 Qtrs
Purchases of equipment and capitalized patents	`PaymentsToAcquireProductiveAssets`	$69.04K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-896.67K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.04K	USD	2 Qtrs
Sale of Common Stock and Warrants	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Sale of Common Stock and Warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$14.55M	USD	2 Qtrs
Exercise of Warrants and Options	`ProceedsFromStockOptionsExercised`	$20.18M	USD	2 Qtrs
Exercise of Warrants and Options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.55M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.18M	USD	2 Qtrs
Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$13.20M	USD	2 Qtrs
Increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.10M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$27.17M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.78M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.07M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$587.56K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$27.17M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.78M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.